|
|
Revised Schedules including all amendments made
by the
Commission on Narcotic Drugs in force as of 1 July 1993*
LIST OF SUBSTANCS IN THE SCHEDULES
List of Substances in Schedule I
|
International
nonproprietary name |
Other nonproprietary
or trivial name |
Chemical name |
| 1. |
BROLAMFETAMINE |
DOB |
(±)-4-bromo-2,5-dimethoxy-a-
methylphenethylamine |
| 2. |
CATHINONE |
|
(-)-(S)-2-aminopropiophenone |
| 3. |
|
DET |
3-[2-(diethylamino)ethyl]indole |
| 4. |
|
DMA |
(±)-2,5-dimethoxy-a-methyl-
phenethylamine |
| 5. |
|
DMHP |
3-(1,2-dimethylheptyl)-7,8,9,10-
tetrahydro-6,6,9-trimethyl-6H-
dibenzo[b,d]pyran-1-ol |
| 6. |
|
DMT |
3-[2-(dimethylamino)ethyl]indole |
| 7. |
|
DOET |
(±)-4-ethyl-2,5-dimethoxy-a-
phenethylamine |
| 8. |
N-ETHYL-
TENAMFETAMINE |
MDE, N-ETHYL-
MDA |
(±)-N-ethyl-a-methyl-3,4-
(methylenedioxy)phenethylamine |
| 9. |
ETICYCLIDINE |
PCE |
N-ethyl-1-phenylcyclohexylamine |
| 10. |
N-HYDROXY-
TENAMFET-
AMINE |
N-OH MDA,
N-HYDROXY-
MDA |
(±)-N-[a-methyl-3,4-(methylene-
dioxy)phenethyl]hydroxyl-
amine |
| 11. |
(+)-LYSERGIDE |
LDS, LSD-25 |
9,10-didehydro-N,N-diethyl-6-
methylergoline-8ß-carboxamide |
| 12. |
|
MDMA |
(±)-N,a-dimethyl-3,4-(methylene-
dioxy)phenethylarnine |
| 13. |
|
mescaline |
3,4,5-trimethoxyphenethylamine |
| 14. |
4-METHYLAMINO-
REX |
|
(±)-cis-2-amino-4-methyl-
5-phenyl-2-oxazoline
(±}-cis-4,5-dihydro-4-methyl-
5-phenyl-2-oxazolamine |
| 15. |
|
MMDA |
2-methoxy-a-methyl-4,5-
(methylenedioxy)phenethylamine |
| 16. |
|
parahexyl |
3-hexyl-7,8,,9,10-tetrahydro-6,6,9-
trimethyl-6H-dibenzo[b,d]
pyran-1-ol |
| 17. |
|
PMA |
p-rnethoxy-a-methylphen-
ethylamine |
| 18. |
|
psilocine,
psilotsin |
3-[2-(dimethylamino)ethyl]
indol-4-ol |
| 19. |
PSILOCYBINE |
|
3-[2-(dimethylamino)ethyl]indol-4-
yl dihydrogen phosphate |
| 20. |
ROLICYCLIDINE |
PHP, PCPY |
1-(1-phenylcyclohexyl)pyrrolidine |
| 21. |
|
STP, DOM |
2,5-dimethoxy-a,4-dimethyl-
phenethylamine |
| 22. |
TENAMFETAMINE |
MDA |
a-methyl-3,4(methylenedioxy)
phenethylamine |
| 23. |
TENOCYCLIDINE |
TCP |
1-[1-(2-thienyl)cyclohexyl]piperidine |
| 24. |
|
tetrahydrocannabinol, the following isomers
and their stereochemical variants |
|
|
|
7,8,9,10-tetrahydro-6,6,9-trimethyl-
3-pentyl-6H-dibenzo[b,d]
pyran-1-ol
(9R., 10aR)-8,9,10,10a-tetrahydro-
6,6,9-trimethyl-3-pentyl-6H-
dibenzo[b,d]pyran-1-ol
(6aR,9R,10aR)-6a,9,10,10a-
tetrahydro-6,6,9-trimethyl-3-
pentyl-6H-dibenzo[b,d]pyran-1-ol
(6aR,10aR)-6a,7,10,10a-tetrahydro-
6,6,9-trimethyl-3-pentyl-6H-
dibenzo[b,d]pyran-1-ol
6a,7,8,9-tetrahydro-6,6,9-trimethyl-
3-pentyl-6H-dibenzo[b,d]
pyran-1-ol
(6aR,10aR)-6a,7,8,9,10,10a-hexa-
hydro-6,6-dimethyl-9-methylene-
3-pentyl-6H-dibenzo[b,d]
pyran-1-ol |
| 25. |
|
TMA |
(±)-3,4,5-trimethoxy-a-methylphen-
ethylamine |
The salts of the
substances listed in this Schedule whenever the existence of such salts is possible.
|
